Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Deferred Tax Assets (2021)

Universe Pharmaceuticals' Current Deferred Tax Assets history spans 1 years, with the latest figure at $7.5 million for Q3 2021.

  • For Q3 2021, Current Deferred Tax Assets changed N/A year-over-year to $7.5 million; the TTM value through Sep 2021 reached $7.5 million, changed N/A, while the annual FY2021 figure was $7.5 million, N/A changed from the prior year.
  • Current Deferred Tax Assets for Q3 2021 was $7.5 million at Universe Pharmaceuticals.
  • Across five years, Current Deferred Tax Assets topped out at $7.5 million in Q3 2021 and bottomed at $7.5 million in Q3 2021.